155 related articles for article (PubMed ID: 3117088)
1. Lymphocyte phenotype and lymphokines following anti-thymocyte globulin therapy in patients with aplastic anaemia.
Platanias L; Gascon P; Bielory L; Griffith P; Nienhuis A; Young N
Br J Haematol; 1987 Aug; 66(4):437-43. PubMed ID: 3117088
[TBL] [Abstract][Full Text] [Related]
2. In vitro interferon-gamma production by cultured T-cells in severe aplastic anaemia: correlation with granulomonopoietic inhibition in patients who respond to anti-thymocyte globulin.
Laver J; Castro-Malaspina H; Kernan NA; Levick J; Evans RL; O'Reilly RJ; Moore MA
Br J Haematol; 1988 Aug; 69(4):545-50. PubMed ID: 3136795
[TBL] [Abstract][Full Text] [Related]
3. Changes in peripheral blood mononuclear cell subpopulations during antithymocyte globulin therapy for severe aplastic anemia.
López-Karpovitch X; Zarzosa ME; Cárdenas MR; Piedras J
Acta Haematol; 1989; 81(4):176-80. PubMed ID: 2502890
[TBL] [Abstract][Full Text] [Related]
4. Lymphokine abnormalities in aplastic anemia: implications for the mechanism of action of antithymocyte globulin.
Gascon P; Zoumbos NC; Scala G; Djeu JY; Moore JG; Young NS
Blood; 1985 Feb; 65(2):407-13. PubMed ID: 2981588
[TBL] [Abstract][Full Text] [Related]
5. Analysis of lymphocyte subsets in patients with aplastic anaemia.
Zoumbos NC; Ferris WO; Hsu SM; Goodman S; Griffith P; Sharrow SO; Humphries RK; Nienhuis AW; Young N
Br J Haematol; 1984 Sep; 58(1):95-105. PubMed ID: 6235836
[TBL] [Abstract][Full Text] [Related]
6. Haematopoietic and immunologic abnormalities in severe aplastic anaemia patients treated with anti-thymocyte globulin.
de Planque MM; Brand A; Kluin-Nelemans HC; Eernisse JG; van der Burgh F; Natarajan AT; Beverstock GC; Zwaan FE; Willemze R; van Rood JJ
Br J Haematol; 1989 Mar; 71(3):421-30. PubMed ID: 2784688
[TBL] [Abstract][Full Text] [Related]
7. Identification of activated T cells and the suppressor/inducer subset in patients suffering from severe aplastic anemia.
Köller U; Hinterberger W; Gschwandtler L; Grümayer R; Majdic O; Knapp W
Blut; 1989 Jan; 58(1):21-6. PubMed ID: 2521803
[TBL] [Abstract][Full Text] [Related]
8. In vitro immunoglobulin production, proliferation, and cell markers before and after antithymocyte globulin therapy in patients with aplastic anemia.
Lum LG; Seigneuret MC; Doney KC; Storb R
Am J Hematol; 1987 Sep; 26(1):1-15. PubMed ID: 2820224
[TBL] [Abstract][Full Text] [Related]
9. Treatment of severe aplastic anaemia with anti-thymocyte globulin.
McCann SR; Sullivan F; Reynolds M; Temperley IJ
Acta Haematol; 1985; 74(3):144-7. PubMed ID: 3938158
[TBL] [Abstract][Full Text] [Related]
10. Treatment of severe aplastic anemia with antithymocyte globulin.
Rothmann SA; Streeter RR; Bukowski RM; Hewlett JS
Exp Hematol; 1982 Oct; 10(9):809-16. PubMed ID: 6983454
[TBL] [Abstract][Full Text] [Related]
11. Aplastic anemia associated with bone marrow suppressor T-cell hyperactivity: successful treatment with antithymocyte globulin.
Amare M; Abdou NL; Robinson MG; Abdou NI
Am J Hematol; 1978; 5(1):25-32. PubMed ID: 311583
[TBL] [Abstract][Full Text] [Related]
12. Comparison of rabbit antithymocyte globulin and Jurkat cell-reactive anti-T lymphocyte globulin as a first-line treatment for children with aplastic anemia.
Xie X; Shi W; Zhou X; Shao Y; Qiao X
Exp Hematol; 2014 Jun; 42(6):431-8. PubMed ID: 24582815
[TBL] [Abstract][Full Text] [Related]
13. [Comparison of two types of antithymocyte globulin in the treatment of children with aplastic anemia].
Xie XT; He W; Shi W; Zhou XX; Qiao XH
Zhonghua Er Ke Za Zhi; 2016 Apr; 54(4):294-8. PubMed ID: 27055431
[TBL] [Abstract][Full Text] [Related]
14. Direct binding of antithymoctye globulin to haemopoietic progenitor cells in aplastic anaemia.
Flynn J; Cox CV; Rizzo S; Foukaneli T; Rice K; Murphy M; Welsh J; Rutherford TR; Gordon-Smith EC; Gibson FM
Br J Haematol; 2003 Jul; 122(2):289-97. PubMed ID: 12846899
[TBL] [Abstract][Full Text] [Related]
15. A proposed mechanism of action for ALG and ATG in severe acquired aplastic anaemia.
Atrah HI; Sandilands GP
J Clin Lab Immunol; 1988 Feb; 25(2):59-62. PubMed ID: 2967377
[TBL] [Abstract][Full Text] [Related]
16. Anti-thymocyte globulin treatment for aplastic anemia.
Jansen J; Zwaan FE; Haak HL; te Velde J; Guiot HF; Sabbe LJ; Eernisse JG; Tricot GJ; van Rood JJ
Scand J Haematol; 1982 Apr; 28(4):341-51. PubMed ID: 7051265
[TBL] [Abstract][Full Text] [Related]
17. Circulating activated suppressor T lymphocytes in aplastic anemia.
Zoumbos NC; Gascón P; Djeu JY; Trost SR; Young NS
N Engl J Med; 1985 Jan; 312(5):257-65. PubMed ID: 2981406
[TBL] [Abstract][Full Text] [Related]
18. Antilymphocyte globulin therapy enhances impaired function of natural killer cells and lymphokine activated killer cells in aplastic anaemia.
Myint AA; Malkovska V; Morgan S; Luckit J; Wonke B; Gordon-Smith EC
Br J Haematol; 1990 Aug; 75(4):578-84. PubMed ID: 2207010
[TBL] [Abstract][Full Text] [Related]
19. Treatment of severe aplastic anemia using antithymocyte globulin with or without an infusion of HLA haploidentical marrow.
Doney KC; Weiden PL; Buckner CD; Storb R; Thomas ED
Exp Hematol; 1981 Sep; 9(8):829-34. PubMed ID: 7035206
[TBL] [Abstract][Full Text] [Related]
20. Successful treatment of chronic refractory pure red cell aplasia with antithymocyte globulin: correlation with in vitro erythroid culture studies.
Mangan KF; Shadduck RK
Am J Hematol; 1984; 17(4):417-26. PubMed ID: 6238526
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
